Stroke · 2011 · 77 citations · 9 references
MedicineNeurologyCerebrovascular NeurosurgeryCerebrovascular SurgeryStroke RehabilitationAcute Stroke CareAcute Stroke ManagementCerebrovascular DiseaseStrokeThrombolytic TherapyAcute Ischemic Stroke ThrombolysisClinical Outcome MeasurementFunctional Outcome EvaluationFunctional Outcome MeasurementIntravenous Tissue Plasminogen ActivatorPlasminogen ActivatorsTelemedicine Stroke AssessmentThrombolysis In Ischemic Stroke
BACKGROUND AND PURPOSE: Telestroke networks offer an opportunity to increase tissue-type plasminogen activator use in community hospitals. METHODS: We compared 83 patients treated with intravenous tissue-type plasminogen activator by telestroke to 59 patients treated after in-person evaluation by the same neurologists at a tertiary care stroke center. Onset and door-to-treatment times and functional outcome at 90 days were obtained prospectively. Favorable outcome was defined as modified Rankin Scale score ≤2. RESULTS: Favorable outcome rates were comparable between the groups (42.1% versus 37.5%, P=0.7). There was no significant difference in the rate of symptomatic hemorrhage. CONCLUSIONS: Telestroke is a viable alternative to in-person evaluation when stroke expertise is not readily available.
9
Telemedicine for Safe and Extended Use of Thrombolysis in Stroke
Heinrich J. Audebert, Christian Kukla, Stephan Clarmann von Claranau et al. · Stroke · 2004 · 241 citations
Long-term outcome after thrombolysis in telemedical stroke care
Stefan Schwab, Bijan Vatankhah, Christian Kukla et al. · Neurology · 2007 · 202 citations